期刊文献+

参芪扶正注射液配合化疗在乳腺癌治疗中的应用效果观察 被引量:3

下载PDF
导出
摘要 目的探讨参芪扶正注射液配合化疗在乳腺癌治疗中的应用效果。方法 96例乳腺癌患者,随机分为观察组和对照组,各48例。观察组患者在常规化疗的基础上给予注射参芪扶正注射液,对照组患者给予常规化疗,比较两组患者的临床疗效和不良反应。结果与对照组相比,观察组在生活质量总改善率83.5%高于对照组60.3%,胃肠道反应发生率低于对照组,白细胞的下降率低于对照组,患者的心功能改善高于对照组,两组疗效比较差异具有统计学意义(P<0.05)。结论参芪扶正注射液配合化疗在乳腺癌治疗中减少了患者的不良反应,改善了患者的生活质量,保护了患者的心脏功能。
作者 李艺 李晓琳
出处 《中国现代药物应用》 2014年第18期152-153,共2页 Chinese Journal of Modern Drug Application
  • 相关文献

参考文献4

二级参考文献19

  • 1王云,杜伟,李醒亚.节律化疗对Lewis肺癌血管生成的影响[J].中国实用医药,2007,2(36):25-27. 被引量:3
  • 2王云,梁宪斌,纪媛媛,李醒亚.环磷酰胺节律化疗的抗血管生成作用探讨[J].山东医药,2006,46(6):17-19. 被引量:7
  • 3董英辉,王敬然,乞国艳,董江波.参芪扶正注射液配合化疗治疗恶性肿瘤的疗效观察[J].现代肿瘤医学,2006,14(12):1607-1608. 被引量:15
  • 4Enrique LA,Ana Carolina SV,Yadira BC,et al.Phase Ⅱ study of metronomic chemotherapy with thalidomide,carboplatin-vincristine-fluvastatin in the treatment of brain stem tumors in children[J].Archiv Med Res,2008,39(7):655-662.
  • 5Caballero M,Grau J,Palmero R,et al.Serum vascular endothelial growth factor as prognostic factor in metronomic weekly paclitaxel treatment for patients with advanced head and neck cancer refractory to platinum-based chemotherapy[J].Radiotherapy Oncology,2007,82:33.
  • 6Emmenegger U,Man S,Shaked Y,et al.A comparative analysis of low-dose metronomic cyclophosphamide reveals absent or low-grade toxicity on tissues highly sensitive to the toxic effects of maximum tolerated dose regimens[J].Cancer Res,2004,64(11):3994-4000.
  • 7Chua DT,Nicholls JM,Sham JS,et al.Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy[J].Int J Radiat Oncol Biol Phys,2004,59(1):11-20.
  • 8Salomon DS,Brandt R,Ciardiello F,et al.Epidermal growth factor-related peptides and their receptors in human malignancies[J].Crit Rev Oncol Hematol,1995,19 (3):183-232.
  • 9Cunningham D,Humblet Y,Siena S,et al.Cetuximab monotherapy and cetuximab plus irinotecan inirinotecan-refractory metastatic colorectal cancer[J].N Engl J Med,2004,351:337-345.
  • 10Bonner JA,Harari PM,Giralt J,et al.Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck[J].N Engl J Med,2006,354(6):567-578.

共引文献41

同被引文献41

  • 1宋辉,邹翔,孙桂超,季宇彬.蛇麻酮通过Fas/FasL途径诱导人肝癌HepG2细胞凋亡机制研究[J].中草药,2009,40(S1):202-205. 被引量:2
  • 2Gorczynski RM,Chen Z,Erin N,et al.Comparison of immunity in mice cured of primary/metastatic growth of EMT6 or 4THM breast cancer by chemotherapy or immunotherapy[J].PLo S One,2014,9(11):e113597.
  • 3Nicolini A,Rossi G,Ferrari P,et al.Clinical and laboratory patterns during immune stimulation in hormone responsive metastatic breast cancer[J].Biomed Pharmacother,2014,68(2):171-178.
  • 4Sun M,Shi H,Liu C,et al.Construction and evaluation of a novel humanized HER2-specific chimeric receptor[J].Breast Cancer Res,2014,16(3):R61.
  • 5Youniss FM,Sundaresan G,Graham LJ,et al.Near-infrared imaging of adoptive immune cell therapy in breast cancer model using cell membrane labeling[J].PLo S One,2014,9(10):e109162.
  • 6Ostadrahimi A,Ziaei JE,Esfahani A,et al.Effect of beta glucan on white blood cell counts and serum levels of IL-4 and IL-12 in women with breast cancer undergoing chemotherapy:a randomized doubleblind placebo-controlled clinical trial[J].Asian Pac J Cancer Prev,2014,15(14):5733-5739.
  • 7Salva E,Turan SO,Kabasakal L,et al.Investigation of the therapeutic efficacy of codelivery of psiRNA-vascular endothelial growth factor and p IL-4 into chitosan nanoparticles in the breast tumor model[J].J Pharm Sci,2014,103(3):785-795.
  • 8Joshi NN,Bhat S,Hake S,et al.Opposing effects of pro-and anti-inflammatory cytokine gene polymorphisms on the risk for breast cancer in western Indian women:a pilot study[J].Int J Immunogenet,2014,41(3):242-249.
  • 9Abdin AA,Soliman NA,Saied EM.Effect of propranolol on IL-10,visfatin,Hsp70,i NOS,TLR2,and survivin in amelioration of tumor progression and survival in Solid Ehrlich Carcinoma-bearing mice[J].Pharmacol Rep,2014,66(6):1114-1121.
  • 10Cecil DL,Holt GE,Park KH,et al.Elimination of IL-10-inducing Thelper epitopes from an IGFBP-2 vaccine ensures potent antitumor activity[J].Cancer Res,2014,74(10):2710-2718.

引证文献3

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部